ENTRY       D06314                      Drug
NAME        Visilizumab (USAN/INN);
            Nuvion (TN)
EFFICACY    Immunosuppressant, Anti-CD3 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of organ transplantation rejection and other T lymphocyte-mediated diseases and disorders, including autoimmune diseases
TARGET      CD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]
  PATHWAY   hsa04660(915+916+917)  T cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3
                 D06314  Visilizumab (USAN/INN)
DBLINKS     CAS: 219716-33-3
            PubChem: 47207971
///
